For the first time in 36 years, the U.S. Congress took a significant step towards fixing the ineffective law that primarily governs the use of toxic chemicals in America’s workplaces, homes, schools, and almost every other facet of our everyday lives. This is a monumental step, not just for the U.S., but for public health … Read More.
After six days and 322 arrests (and counting), the Tar Sands Action is in full effect. This two-week long protest is being staged on the sidewalk in front of the White House in Washington, DC, plainly visible to government employees, diplomats and tourists alike. Concerned citizens have travelled from all 50 states and Canada to … Read More.
On Tuesday, the US Dept. of Energy announced it was distributing $575 million USD in grants to 22 projects in 15 states, in an effort to deploy Carbon Capture and Storage / Sequestration (CCS) technology within the next 10 years. The money was allocated under the Economic Stimulus package (ARRA 2009). The Washington Post reports … Read More.
Government energy ministers gathering in Washington, D.C., today launched 11 energy-efficiency and renewable energy initiatives around the world, which they claim will avoid the need to build 500 midsize power plants during the next 20 years. via www.nytimes.com Of particular note is that “the United States and a dozen other nations will create what is … Read More.
During Colombia’s periodic review by the Office of the UN High Commissioner for Human Rights, specifically the Committee on Economic, Social and Cultural Rights, several recommendations were made relating to intellectual property (IP) rights. The official UN report can be found here and CIEL’s publications relating to Trade Agreements and IP can be accessed here. … Read More.
The past thirty days have given those who follow developments in innovation policy quite a bit of material. First, on March 29th, a US district court (SDNY) held that neither isolated genes nor methods of analyzing or comparing genes were patentable subject matter in Association for Molecular Pathology v. US Patent and Trademark Office (USPTO). … Read More.